Dopamine and serotonin systems in human and rodent brain: effects of age and neurodegenerative disease.
about
Changes in brain striatum dopamine and acetylcholine receptors induced by chronic CDP-choline treatment of aging miceThe role of free radicals in the aging brain and Parkinson's Disease: convergence and parallelismImpaired Brain Dopamine and Serotonin Release and Uptake in Wistar Rats Following Treatment with CarboplatinBehavioural responses to the selective D1-dopamine receptor agonist R-SK&F; 38393 and the selective D2-agonist RU 24213 in young compared with aged ratsBehavioral disturbances of dementia.Effects of Lifelong Ethanol Consumption on Brain Monoamine Transmitters in Alcohol-Preferring Alko Alcohol (AA) Rats.Soluble beta amyloid(1-42): a critical player in producing behavioural and biochemical changes evoking depressive-related state?L-DOPA reverses motor deficits associated with normal aging in mice.Genetics and the pathobiology of ageing.Age-related changes in motor cortical properties and voluntary activation of skeletal muscleDynapenia and aging: an update.Drug development and use in the elderly: search for the right dose and dosing regimen (Parts I and II).Learning and generalization in healthy aging: implication for frontostriatal and hippocampal function.Evolving concepts on the age-related changes in "muscle quality".Quantification of reserve pool dopamine in methionine sulfoxide reductase A null miceDopamine and aging: intersecting facets.Role of ERK1, 2, and 5 in dopamine neuron survival during aging.Difference in muscle quality over the adult life span and biological correlates in the Baltimore Longitudinal Study of Aging.The Effects of Age, from Young to Middle Adulthood, and Gender on Resting State Functional Connectivity of the Dopaminergic Midbrain.Pharmacodynamic issues relevant to geriatric psychopharmacology.Pharmacogenomic implications of variants of monoaminergic-related genes in geriatric psychiatry.The ageing brain, neuroleptic drugs and the enigma of schizophrenia.Characteristic difficulty in rhythmic movement with aging and its relation to Parkinson's disease.Spontaneous long-term compensatory dopaminergic sprouting in MPTP-treated mice.Reduced brain-derived neurotrophic factor is associated with a loss of serotonergic innervation in the hippocampus of aging mice.Direct catecholaminergic-cholinergic interactions in the basal forebrain. I. Dopamine-beta-hydroxylase- and tyrosine hydroxylase input to cholinergic neurons.Age-related modifications of the morphological organization of pituicytes are associated with alteration of the GABAergic and dopaminergic innervation afferent to the neurohypophysial lobe.Aging alters electroencephalographic and clinical manifestations of kainate-induced status epilepticus.Brain aging phenomena in migrating sockeye salmon Oncorhynchus nerka nerka.Dopaminergic changes in the basal ganglia. A generalized phenomenon of aging in mammals.Skeletal muscle performance and ageing.Physical activity modulates corticospinal excitability of the lower limb in young and old adults.Human Striatal Dopaminergic and Regional Serotonergic Synaptic Degeneration with Lewy Body Disease and Inheritance of APOE ε4.Age differences in arterial and venous extra-cerebral blood flow in healthy adults: contributions of vascular risk factors and genetic variants.Histology and histochemistry of the aging cerebral cortex: an overview.Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.Chronological age impacts immunotherapy and monocyte uptake independent of amyloid load.Novel Therapeutic Strategies for Delirium in Patients With Cancer: A Preliminary Study.Quantitative morphological changes in neurons and glia in the frontal lobe of the aging rat.
P2860
Q24680154-A98E5EC6-729B-4CEE-B983-9C28DDEC93D9Q26852148-EB729806-89C2-4C20-94F2-1D4842979691Q27300384-048BA57F-3031-4A15-8483-C696A96A36CFQ28360096-22ECB822-0319-4BB9-95B5-C15A6FF8BB47Q33609591-DFA3A777-B7E4-4E38-9BD3-F5D674F8A68EQ33772132-58F8C123-38C3-47F5-BCD8-E6A169F1D66BQ34078777-8FF4F4CE-586A-45FB-8806-5D447B9C977AQ34482342-493DD0AA-DAFE-46E5-B6B0-20E5B05A9907Q35211822-0A890891-567A-4425-B0BB-C351D85E5870Q35250436-911CC0C5-313E-4AB4-B7C4-2FCA168183E8Q35678530-8D6CC4E4-7E5A-4D1D-B440-A0943C0AD4C4Q35826495-9306101F-52DC-4C65-A5A9-E8A6DAD49683Q35992695-31BA40D1-FB79-4E51-A8E3-51369752E550Q36028216-DF619F26-2045-4E0D-8318-817FC1456025Q36253524-1BA3350F-A0F3-47A1-9DD7-0276B6056793Q37289286-4AE19050-9A90-4CC2-863E-BB89FAD2F870Q37497595-F0D09E99-43F0-4738-9F64-A97C53A867A7Q37622719-01F24B92-F173-4E32-A513-5E4CBDE8F403Q37627147-36A77092-F830-40A1-AAA3-380A3F90A9C8Q37781948-C19B20D2-93FE-4615-880C-1AB3BEF7A539Q37791156-498D6DD5-4A14-4E32-9807-B97C350ABC2FQ39472243-264EDC91-9A66-404D-9F65-6A867C8E9977Q41420706-5C3960C4-9FE5-44A8-9BAD-C3D58AE75327Q42494199-596DD3E7-037A-4326-BC7E-DADD081DDB10Q42505227-A1D15BDD-4E71-4AFF-97A4-592091D1A4FDQ42526773-D7703514-3048-45B2-BDDC-790E9965E8B4Q44658260-1341ACBF-270D-4C9C-B0FE-49CF702E5482Q45088289-9EE0F44B-20D8-47C3-922F-B93D6D5CE968Q45245185-D50526E2-E347-4B82-93BF-E5D296671544Q46322618-E214B5B6-D4B6-4807-925E-907C8A1A37E6Q47450273-0E601FF1-0E76-4803-991D-77127BF6AEF3Q48155951-0E1FE535-6FA3-4E47-92A0-315D43CC52A0Q48303839-7254EE7D-2654-4A35-A1ED-1B095DA8511BQ48340994-EC26F84C-7063-4755-88BE-B0B59630C63BQ48342169-CD56BE7D-00F2-4A24-8ADD-3E5F95A52D31Q48477072-26E3C17A-B3A6-49BD-B749-64A5CFD59DE3Q48748554-CF74D1E0-7D22-43E1-BFA4-0379D5F9E755Q50454201-BAAB0036-5E88-4E65-80D4-30BF48FF0B12Q52061363-961BF055-0FEF-4E1C-B8DC-97041819CA37
P2860
Dopamine and serotonin systems in human and rodent brain: effects of age and neurodegenerative disease.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Dopamine and serotonin systems ...... and neurodegenerative disease.
@en
Dopamine and serotonin systems ...... and neurodegenerative disease.
@nl
type
label
Dopamine and serotonin systems ...... and neurodegenerative disease.
@en
Dopamine and serotonin systems ...... and neurodegenerative disease.
@nl
prefLabel
Dopamine and serotonin systems ...... and neurodegenerative disease.
@en
Dopamine and serotonin systems ...... and neurodegenerative disease.
@nl
P2093
P2860
P921
P1476
Dopamine and serotonin systems ...... and neurodegenerative disease.
@en
P2093
P2860
P304
P356
10.1111/J.1532-5415.1987.TB04641.X
P407
P577
1987-04-01T00:00:00Z